HIV-positive TB patients on ART (antiretroviral therapy) in Djibouti
Djibouti: HIV-positive TB patients on ART (antiretroviral therapy) was 71.0% in 2024. ◆ Volatile
Latest (2024)
71.0%
Change on year
up 4.4%
World rank
124th
of 144 countries
All-time high
97.0%
in 2015
All-time low
11.0%
in 2010
Years of data
19
2003–2024
HIV-positive TB patients on ART (antiretroviral therapy) in Djibouti, 2003–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Djibouti recorded 71.0% for hiv-positive tb patients on art (antiretroviral therapy) in 2024.
Compared with earlier readings it is up 4.4% on the previous year and up 4.4% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in Djibouti peaked at 97.0% in 2015 and was at its lowest, 11.0%, in 2010.
That places Djibouti 124th out of 144 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
HIV-positive TB patients on ART (antiretroviral therapy) in Djibouti, year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 21.0% | — |
| 2004 | 14.0% | -33.3% |
| 2005 | 15.0% | +7.1% |
| 2008 | 29.0% | +93.3% |
| 2009 | 23.0% | -20.7% |
| 2010 | 11.0% | -52.2% |
| 2011 | 22.0% | +100.0% |
| 2012 | 75.0% | +240.9% |
| 2013 | 35.0% | -53.3% |
| 2014 | 68.0% | +94.3% |
| 2015 | 97.0% | +42.6% |
| 2016 | 76.0% | -21.6% |
| 2017 | 57.0% | -25.0% |
| 2018 | 63.0% | +10.5% |
| 2019 | 52.0% | -17.5% |
| 2020 | 36.0% | -30.8% |
| 2021 | 50.0% | +38.9% |
| 2022 | 68.0% | +36.0% |
| 2024 | 71.0% | +4.4% |
Djibouti compared with similar countries
- Djibouti's 71.0% is below the median for lower middle income countries, which is 96.0%, 74% of the median. (43 countries reporting)
- Djibouti's 71.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 100.0%, 71% of the median. (19 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 20.4% | 14.0% | 29.0% | 5 |
| 2010s | 55.6% | 11.0% | 97.0% | 10 |
| 2020s | 56.2% | 36.0% | 71.0% | 4 |
Countries ranked near Djibouti
More health data for Djibouti
- Un projection of annual infant deaths, annual growth rate -1.5 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2173 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,107 deaths per 1,000 people (2090)
- Number of infants who die before age 1 197 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.5299 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0481 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.5304 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in Djibouti?
- Hiv-positive tb patients on art (antiretroviral therapy) in Djibouti was 71.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in Djibouti?
- The highest recorded value was 97.0% in 2015.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in Djibouti?
- The lowest recorded value was 11.0% in 2010.
- How does Djibouti rank for hiv-positive tb patients on art (antiretroviral therapy)?
- Djibouti ranks 124th out of 144 countries with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in Djibouti?
- Over the last ten years it is up 4.4%. The long-run trend across the full record is volatile.
- Where does this Djibouti data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 19 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).